As a transcription factor, ASCL2 also has been identified as a WNT/β-catenin target gene, and which was shown to be expressed in the mouse intestinal crypt as well as human and mouse intestinal cancers [37]. The gene discussed is ASCL2; the disease is intestinal cancer.